Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (10881)	7/22/1999 10:27:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Business plans???? Do you mean sales or earnings projections? The latter hardly constitute a business plan. It appears that companies do all they can to get the whisper numbers as low as possible and creative accounting as active as possible. An FDA turndown is a bit more serious than failure to meet projections. When people lose 40% of their investment in one type of stock in a day and realize how difficult, costly and time-consuming is many of them will decide it is better to invest in other areas where reality takes longer to intrude. Can a stock be hyped in the short term? Yes, of course. Will the biotech industry boon? Don't think so. I still doubt that there will be a consolidation among the smaller biotechs, with one merging or buying out another. Still think this will be a game of the big guys buying up their specific targets. This is an unpopular view on other boards, too. I have never had much luck at buying a stock just because it was benefiting from spin. Do you think that is why XOMA has gone up?